Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)
NCT00110929
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
850
Enrollment
INDUSTRY
Sponsor class
Conditions
End Stage Renal Disease
Interventions
DRUG:
AMG 073
Sponsor
Amgen